The University of Chicago Header Logo

Connection

Tong-Chuan He to Neoplasms

This is a "connection" page, showing publications Tong-Chuan He has written about Neoplasms.
Connection Strength

0.971
  1. Pyrvinium doubles against WNT-driven cancer. J Biol Chem. 2022 10; 298(10):102479.
    View in: PubMed
    Score: 0.301
  2. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest. 2016 Feb; 96(2):116-36.
    View in: PubMed
    Score: 0.188
  3. Ginseng saponin metabolite 20(S)-protopanaxadiol inhibits tumor growth by targeting multiple cancer signaling pathways. Oncol Rep. 2013 Jul; 30(1):292-8.
    View in: PubMed
    Score: 0.157
  4. Wnt/beta-catenin signaling pathway as a novel cancer drug target. Curr Cancer Drug Targets. 2004 Dec; 4(8):653-71.
    View in: PubMed
    Score: 0.088
  5. Effect of antibiotic monensin on cell proliferation and IGF1R signaling pathway in human colorectal cancer cells. Ann Med. 2023 12; 55(1):954-964.
    View in: PubMed
    Score: 0.082
  6. Red ginseng and cancer treatment. Chin J Nat Med. 2016 Jan; 14(1):7-16.
    View in: PubMed
    Score: 0.047
  7. Regulation of cell proliferation and migration by p62 through stabilization of Twist1. Proc Natl Acad Sci U S A. 2014 Jun 24; 111(25):9241-6.
    View in: PubMed
    Score: 0.042
  8. The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol. 2010 06; 25(6):795-806.
    View in: PubMed
    Score: 0.032
  9. Tyrosine kinase inhibitor STI-571: the new wonder drug of cancer therapy. Cancer Biol Ther. 2004 Apr; 3(4):393-4.
    View in: PubMed
    Score: 0.021
  10. Converting cancer genes into killer genes. Proc Natl Acad Sci U S A. 1996 Apr 30; 93(9):4192-6.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.